Statin trials in progress: unanswered questions.

被引：6

作者：

Davidson M.H. ^{[1
]}

机构：

[1] Chicago Center for Clinical Research, Rush Presbyterian-St. Luke's, 515 North State Street, Chicago, 60610, IL

来源：

Current Atherosclerosis Reports | 2001年 / 3卷 / 1期

关键词：

Simvastatin; Atorvastatin; Pravastatin; Fluvastatin; Cerivastatin;

D O I：

10.1007/s11883-001-0004-0

中图分类号：

学科分类号：

摘要：

Five years ago, many critics questioned the value of lipid-lowering therapy. Today, the clinical benefits of statins are well documented, but the challenge remains to fully implement these benefits across the wide spectrum of the at-risk population, and continue to advance our understanding regarding the potential for the benefits of statins across an even broader range of select patient populations.

引用

页码：9 / 13

页数：4

共 21 条

[1]

Sacks FM(1996)The effect of parvastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1001-1009

[2]

Pfeffer MA(1995)Prevention of coronary heart disease with paravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1301-1307

[3]

Moyle IA(2000)Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation 101 77-84

[4]

Shepherd J(1998)Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 605-618

[5]

Cobbe SM(1998)Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial Circulation 97 1446-1452

[6]

Ford II(2000)Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial Circulation 102 157-165

[7]

Gotto AM(1999)Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators N Engl J Med 341 70-76

[8]

Whitney E(undefined)undefined undefined undefined undefined-undefined

[9]

Stein FA(undefined)undefined undefined undefined undefined-undefined

[10]

Hulley S(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 →